Arkolith/Insider Trading/ARWR/Form 4

Waddill William D.

DirectorARROWHEAD PHARMACEUTICALS, INC. (ARWR) · full profile →Form 4 · filed Dec 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$566K
Net Open-Market Flow
-$566K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2025Sell(S)5K$68.01$371K57K
Dec 19, 2025Sell(S)2K$66.66$161K63K
Dec 19, 2025Sell(S)500$68.53$34K57K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001553338-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML